165 related articles for article (PubMed ID: 34643484)
1. The role of kidney function on patient survival after percutaneous coronary intervention for acute coronary syndrome in left main coronary artery disease.
Balevski I; Burja S; Petreski T; Piko N; Arva V; Kanič V; Bevc S
Clin Nephrol; 2021 Suppl; 96(1):1-5. PubMed ID: 34643484
[TBL] [Abstract][Full Text] [Related]
2. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial.
Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW
J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952
[TBL] [Abstract][Full Text] [Related]
3. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
5. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
[TBL] [Abstract][Full Text] [Related]
7. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
[TBL] [Abstract][Full Text] [Related]
9. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Versus Without Chronic Kidney Disease.
Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Takeji Y; Kadota K; Imada K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Kato E; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T
Am J Cardiol; 2021 Apr; 145():37-46. PubMed ID: 33454346
[TBL] [Abstract][Full Text] [Related]
11. Rates of future hemodialysis risk and beneficial outcomes for patients with chronic kidney disease undergoing recanalization of chronic total occlusion.
Shimura T; Yamamoto M; Tsuchikane E; Teramoto T; Kimura M; Matsuo H; Kawase Y; Suzuki Y; Kano S; Habara M; Nasu K; Kinoshita Y; Terashima M; Matsubara T; Suzuki T
Int J Cardiol; 2016 Nov; 222():707-713. PubMed ID: 27521544
[TBL] [Abstract][Full Text] [Related]
12. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.
Tomaszuk-Kazberuk A; Nikas D; Lopatowska P; Młodawska E; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Sobkowicz B; Goudevenos I
Kidney Blood Press Res; 2018; 43(6):1796-1805. PubMed ID: 30504712
[TBL] [Abstract][Full Text] [Related]
13. Prognostic of different glomerular filtration rate formulas in patients receiving percutaneous coronary intervention: insights from a multicenter observational cohort.
Chen W; Chen P; Ni Z; Liu Y; Guo W; Jiang L; Wei X; Chen J; Tan N; He P; Guo Y
BMC Cardiovasc Disord; 2020 Jul; 20(1):341. PubMed ID: 32682399
[TBL] [Abstract][Full Text] [Related]
14. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.
Otsuka K; Shimada K; Katayama H; Nakamura H; Ishikawa H; Takeda H; Fujimoto K; Kasayuki N; Yoshiyama M
Heart Vessels; 2019 May; 34(5):735-744. PubMed ID: 30386919
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
Baber U; Farkouh ME; Arbel Y; Muntner P; Dangas G; Mack MJ; Hamza TH; Mehran R; Fuster V
Eur Heart J; 2016 Dec; 37(46):3440-3447. PubMed ID: 27572072
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in Invasive Management and In-Hospital Mortality of Patients With Non-ST Elevation Acute Coronary Syndromes and Chronic Kidney Disease.
De Luca L; Di Pasquale G; Gonzini L; Uguccioni M; Olivari Z; Casella G; Boccanelli A; De Servi S; Urbinati S; Colivicchi F; Gabrielli D; Savonitto S
Angiology; 2021 Mar; 72(3):236-243. PubMed ID: 33021092
[TBL] [Abstract][Full Text] [Related]
18. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
